Evidence map›Paper›PMID 34797525›Full record

SynthesisJournal of neuro-oncology2021

Thalamic gliomas in adults: a systematic review of clinical characteristics, treatment strategies, and survival outcomes.

Paolo Palmisciano, Tarek Y El Ahmadieh, Ali S Haider, Othman Bin Alamer, Faith C Robertson, Aaron R Plitt, Salah G Aoun, Kenny Yu, Aaron Cohen-Gadol, Nelson S Moss and 2 more

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Journal of neuro-oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 4 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 4 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Paolo PalmiscianoDepartment of Neurological Surgery, Trauma Center, Gamma Knife Center, Cannizzaro Hospital, Catania, Italy.ORCID http://orcid.org/0000-0003-0711-3975
Tarek Y El AhmadiehDepartment of Neurological Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. telahmadieh@gmail.com.ORCID http://orcid.org/0000-0002-7122-4349
Ali S HaiderTexas A&M University College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0002-4368-871X
Othman Bin AlamerKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Faith C RobertsonDepartment of Neurological Surgery, Massachusetts General Hospital, Boston, MA, USA.
Aaron R PlittDepartment of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Salah G AounDepartment of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Kenny YuDepartment of Neurological Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA.
Aaron Cohen-GadolDepartment of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
Nelson S MossDepartment of Neurological Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA.
Toral R PatelDepartment of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Raymond SawayaDepartment of Neurological Surgery, MD Anderson Cancer Center, Houston, TX, USA.
Neurological Surgery · USMemorial Sloan Kettering Cancer Center · USKing Abdullah International Medical Research Center · SAMassachusetts General Hospital · USOspedale Cannizzaro · ITTexas A&M University · USThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThalamic gliomas are rare neoplasms that pose significant surgical challenges. The literature is limited to single-institution retrospective case series. We systematically review the literature and describe the clinical characteristics, treatment strategies, and survival outcomes of adult thalamic gliomas.

methodsRelevant articles were identified on PubMed, Scopus, and Cochrane databases. Papers containing cases of adult thalamic gliomas with clinical outcome data were included. A comprehensive review of clinical characteristics and survival analysis was conducted.

resultsWe included 25 studies comprising 617 patients. The median age was 45 years (male = 58.6%). Glioblastoma was the most frequent histological type (47.2%), and 82 tumors were H3 K27M-mutant. Motor deficit was the most common presenting symptom (51.8%). Surgical resection was performed in 69.1% of cases while adjuvant chemotherapy and radiotherapy were administered in 56.3% and 72.6%, respectively. Other treatments included laser interstitial thermal therapy, which was performed in 15 patients (2.4%). The lesion laterality (P = 0.754) and the surgical approach (P = 0.111) did not correlate with overall survival. The median progression-free survival was 9 months, and the overall two-year survival rate was 19.7%. The two-year survival rates of low-grade and high-grade thalamic gliomas were 31.0% and 16.5%, respectively. H3 K27M-mutant gliomas showed worse overall survival (P = 0.017).

conclusionAdult thalamic gliomas are associated with poor survival. Complete surgical resection is associated with improved survival rates but is not always feasible. H3 K27M mutation is associated with worse survival and a more aggressive approach should be considered for mutant neoplasms.

Indexed as

Brain NeoplasmsGliomaHistonesHumansMiddle AgedMutationRetrospective StudiesHistonesAdultGlioblastomaGliomaH3 K27MNeuro-oncologyThalamus

Identifiers

PMID34797525
OpenAlexW3214559838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.